GSK licenses oral insulin from Nobex

By Business Review Editor

Pharma Deals Review: Vol 2002 Issue 25 (Table of Contents)

Published: 2 Jun-2002

DOI: 10.3833/pdr.v2002.i25.1047     ISSN: 1756-7874

Section: Licensing

Fulltext:

Abstract

GlaxoSmithKline entered into a deal with Nobex to co-develop oral insulin compounds for treating diabetes...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details